Neuron23 Funding & Investors
Neuron23™ Inc. is an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases.
neuron23.comTotal Amount Raised: $213,500,000
Neuron23 Funding Rounds
Series C
$100,000,000
Series C Investors
SoftBank Vision FundWestlake Village BioPartnersKleiner Perkins Caufield & ByersHBM PartnersRedmile GroupPerceptive AdvisorsAcorn BioventuresCowen Healthcare InvestmentsSurveyor CapitalSeries B
$80,000,000
Series B Investors
Redmile GroupSurveyor CapitalCowen Healthcare InvestmentsAcorn BioventuresHBM PartnersKleiner Perkins Caufield & ByersWestlake Village BioPartnersPerceptive AdvisorsHBM Healthcare InvestmentsSeries A
$33,500,000
Series A Investors
Kleiner Perkins Caufield & ByersWestlake Village BioPartners
Funding info provided by Diffbot.